Navigation Links
A Weight Neutral Oral Antidiabetic Drug Would Earn a 25 Percent Patient Share in the Type 2 Diabetes Drug Market
Date:7/1/2008

Advantages in Efficacy and Safety Will Make Liraglutide the New Clinical

Gold Standard Drug by 2011, According to a New Report from Decision

Resources

WALTHAM, Mass., July 1 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a weight neutral oral antidiabetic drug would earn a 25 percent patient share in the treatment of type 2 diabetes, according to surveyed primary care physicians. Given the prices set for each of the drug profiles and the size of the type 2 diabetic patient population in 2011, a 25 percent patient share would result in sales of $4.1 billion for an agent fitting the report's Minimal Acceptable drug profile and $8.1 billion for an agent fitting the report's Major Achievement profile.

The new report entitled Type 2 Diabetes: Blockbuster-Bound Januvia Addresses Physicians' Concern over Hypoglycemia also finds that Novo Nordisk's liraglutide will become the new Decision Resources' proprietary clinical gold standard for the treatment of type 2 diabetes by 2011 as surveyed primary care physicians indicate that liraglutide has competitive advantages in terms of efficacy and safety in comparison to the current gold standard, metformin. Although liraglutide has disadvantages in the area of delivery because of its subcutaneous injectable formulation, its positive efficacy and safety attributes offset its disadvantage in delivery.

"Interviewed primary care physicians also state that liraglutide offers a considerable advantage over other current and emerging type 2 diabetes therapies in terms of weight loss," said Donny Wong, Ph.D., principal analyst at Decision Resources. "As a result, we forecast liraglutide to become the clinical gold standard among the agents covered in our analysis."

About the Report

Type 2 Diabetes: Blockbuster-Bound Januvia Addresses Physicians' Concern over Hypoglycemia is a DecisionBase 2008 report from Decision Resources. DecisionBase 2008 combines market forecasts with clinical and commercial end points to assess market share projections in 35 indications. These outputs are driven by quantitative and qualitative primary research. DecisionBase 2008 provides detailed market share, patient share, and price-per-day projections for emerging drugs in development. The market share projections are based on prescriber surveys that compare physicians' expectations of a potential target product profile with an emerging product profile of the leading drugs in development.

The report can be purchased by contacting Decision Resources. Members of the media may request an interview with an analyst.

About Decision Resources

Decision Resources (http://www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

Elizabeth Marshall

Decision Resources

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. High Birth Weight Doubles Risk of Rheumatoid Arthritis
2. Weight Watchers Receives Adverse U.K. VAT Ruling
3. Heavy birthweight increases risk of developing rheumatoid arthritis
4. Heavy birthweight babies twice as likely to develop rheumatoid arthritis
5. One Year Later, Millions are Losing Weight with alli(R)
6. Weight gain within the normal range increases risk of chronic kidney disease
7. Big, Well-Balanced Breakfast Aids Weight Loss
8. Minimally-invasive weight loss surgery improves health and morbidly obese teens
9. Weight Loss After Gastric Bypass Is Key to Easing Diabetes
10. A Simple Weight Loss Diet: Scientific, Safe and Basically Free
11. Weight loss after gastric bypass surgery may protect against infection and cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 23, 2017 , ... "ProRandom is a set of camera tools that allow video editors to ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , With ... with video footage. ProRandom works by using a virtual camera to create the illusion ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... (OREF), in partnership with the American Society of Anesthesiologists® (ASA®), the Foundation ... the American Academy of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, encourages ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... “The Inn at the Mill”: a ... unexpected fears in her quest to become happy and content. , “The Inn at ... Pennsylvania, has also lived in Germany and Vermont and is now living in Berks County ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources to assist in teaching communities and ... resources have been developed for use by nutrition educators and influencers within ...
(Date:1/23/2017)... ... ... Infallible Characteristics of Christ”: a fascinating and entrancing novel exploring the gifts and ... author, Rev. Dr. Robert W. Thomas, the third of seven siblings. He was a ... pastor for over fifteen years. He is a graduate of N.C. College of Theology ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Jan. 23, 2017 The Pharmacy Technician ... implementation of the planned 2020 accredited education requirement ... originally announced in 2013 that the requirement would ... road map of program changes designed to keep ... the pharmacy. "We have determined ...
(Date:1/23/2017)... Jan. 23, 2017 Endo International plc (NASDAQ ... (FTC) today filed a joint motion in the U.S. ... California seeking the entry of a ten-year ... all disputes between the FTC and Endo relating to ... with its Opana® ER and Lidoderm® products.  It also ...
(Date:1/23/2017)... YORK , Jan. 23, 2017 Consolidated ... Partners and Driving the Stability Testing Outsourcing Market ... market addresses market sizing, emerging trends, and technologies, and ... market. The base year is 2015 and forecasts are ... is expected to grow at a CAGR of 9.4% ...
Breaking Medicine Technology: